gms | German Medical Science

28. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie

11.11. - 12.11.2021, digital


Meeting Abstract (21gaa01)

Reduction of medicines by GPs in frail elderly patients using a standardised deprescribing manual during family conferences – the COFRAIL study

Bencheva V, Gogolin M, Mann NK, Schmiedl S, Abraham J, Drewelow E, Ritzke M, Icks A, Mortsiefer A, Wiese B, Wilm S, Thürmann PA
Meeting Abstract (21gaa02)

Prioritisation of adverse drug events leading to hospital admission and occurring during hospitalisation: A RAND survey

Böhmer A, Härdtlein A, Rottenkolber M, Pudritz YM, Dreischulte T, Jaehde U
Meeting Abstract (21gaa03)

A prospective study on the tolerability of vaccines against SARS-CoV-2 in hospital staff

Dedroogh S, Graf K, Schmiedl S, Thürmann PA, Koß R, Theis C, Tebbenjohanns J, Thal S, Dedroogh M
Meeting Abstract (21gaa04)

Guidelines for drug therapy after osteoporosis-associated bone fractures: to what extent are they followed in everyday practice?

Eichler U, Langner I, Schüssel K, Selke GW
Meeting Abstract (21gaa05)

Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave

Enners S, Gradl G, Kieble M, Böhm M, Laufs U, Schulz M
Meeting Abstract (21gaa06)

Cannabis-Report 2020 – An analysis of prescriptions of cannabinoid-based medicinal products based on data of the Mobil health insurance from 2017 until October 2019

Glaeske G, Muth L
Meeting Abstract (21gaa07)

Prescription of potentially teratogenic drugs in women of childbearing age and during first trimester of pregnancy in a large cohort of statutory health insured women

Lappe V, Schubert I, Grandt D
Meeting Abstract (21gaa08)

Updating and expanding the PRISCUS list – Results from the Delphi survey

Mann NK, Mathes T, Sönnichsen A, Pieper D, Moussa M, Thürmann PA
Meeting Abstract (21gaa09)

Differential effects of beta-blocker exposures in predicting specific readmissions for heart failure and myocardial infarction

Meid A, Wirbka L, Ruff C, Haefeli W
Meeting Abstract (21gaa10)

Bewertungskriterien für Gesundheitsapps zur Unterstützung der Medikamenteneinnahme in frühen Entwicklungsphasen der Technologie – ein Scoping Review

Niemann A, Hüer T, Neumann A, Wasem J, Neusser S
Meeting Abstract (21gaa11)

Risk of fall injuries while taking hypnotics, antidepressants, and analgesics

Oehler P, Rottenkolber M, Drey M, Gensichen J, Dreischulte T
Meeting Abstract (21gaa12)

From vaccine approval to reimbursement: an analysis of discrepancies between label according to marketing authorization and indication for reimbursement listed in the Vaccination Policy (SI-RL) in Germany

Prünte L, Barth M, Urban J
Meeting Abstract (21gaa13)

Melanoma reported as an adverse drug reaction

Sachs B, Dubrall D, Kraywinkel K, Schulz M, Schmid M, Bäte J, Fischer-Barth W
Meeting Abstract (21gaa14)

Changes in drug prescriptions during the SARS-CoV-2 pandemic

Schüssel K, Selke GW
Meeting Abstract (21gaa15)

Corona pandemic-related differences in drug prescriptions within the outpatient treatment of the Statutory Health Insurance in Schleswig-Holstein from 2019 until 2020

Schuster R, Emcke T
Meeting Abstract (21gaa16)

Serious Adverse Drug Reactions of Fluoroquinolones: a Pharmacoepidemiological Real World Data Analysis – Study Protocol

Wicherski J, Heß S, Röthlein C, Schüssel K, Brückner G, Schlotmann A, Schröder H, Kern W, Weltermann B, Haenisch B
Meeting Abstract (21gaa17)

The Role of adherence to multiple guideline medications in predicting specific readmissions for heart failure and myocardial infarction

Wirbka L, Ruff C, Haefeli W, Meid A